FDA promises new vaccine ‘framework’ for industry

Taking stock of the drug industry, from the lab to the medicine chest

May 15, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Jose Luis Magana/AP STAT+ | FDA commissioner says new vaccine 'framework' for industry is coming within weeks A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA's expectations for vaccines. By Lizzy Lawrence STAT+ | What to know about Summit Therapeutics' looming clinical trial readout In this week's edition of "Adam's Biotech Scorecard," Adam offers a preview of what may be the most important study readout coming this summer. By Adam Feuerstein Opinion: Ensuring most-favored nation drug pricing doesn't sicken us If the U.S. rationalizes how it pays for medicines, consumers, employers, and government payers would see fair prices. By Darius Lakdawalla and Dana P. Goldman Children's Hospital of Philadelphia CRISPR is used in landmark treatment to correct genetic misspelling of a single patient In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized treatments of rare diseases. By Jason Mast Trump's drug-pricing plan and a potential Theranos 2.0 STAT reporters chat about Trump's drug-pricing plan, RFK Jr.'s congressional hearings, and a new blood-testing company. By Elaine Chen and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser